Reuters logo
BRIEF-Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale
April 12, 2017 / 11:30 AM / 8 months ago

BRIEF-Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale

April 12 (Reuters) - Juniper Pharmaceuticals Inc

* Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale of company

* Krensavage Asset Management LLC, a 2.2% shareholder of Juniper Pharmaceuticals, publishes open letter Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below